Skip to main content
Genetic Testing and Molecular Biomarkers logoLink to Genetic Testing and Molecular Biomarkers
. 2023 Jun 29;27(6):202. doi: 10.1089/gtmb.2022.0141.correx

Correction to: Identifying Mitochondrial Transcription Factor A As a Potential Biomarker for the Carcinogenesis and Prognosis of Prostate Cancer, by Yaqiong Tian, et al. Genet Test Mol Biomarkers 2023; (vol. 27, no. 1; 5–11); doi: 10.1089/gtmb.2022.0141

PMCID: PMC10398721  PMID: 37158849

In the January 2023 issue of Genetic Testing and Molecular Biomarkers (vol. 27, no. 1; pp. 5–11) the article entitled “Identifying Mitochondrial Transcription Factor A As a Potential Biomarker for the Carcinogenesis and Prognosis of Prostate Cancer” by Yaqiong Tian et al. requires correction.

This article was originally published under the copyright of Mary Ann Liebert, Inc. publishers. It has now been updated to reflect Open Access, with copyright transferred to the author(s), and a Creative Commons License (CC-BY) added (http://creativecommons.org/licenses/by/4.0). The CC-BY license went into effect 10 May 2023.

The online version of this article has been corrected to reflect this.


Articles from Genetic Testing and Molecular Biomarkers are provided here courtesy of SAGE Publications

RESOURCES